Articles dans des revues avec comité de lecture (81)
1.
Najar, M., Bouhtit, F., Rahmani, S., Bouali, A., Melki, R., Najimi, M., Lewalle, P., & Merimi, M. (2024). The immunogenic profile and immunomodulatory function of mesenchymal stromal / stem cells in the presence of Ptychotis verticillata. Heliyon, 10(3), e24822. doi:10.1016/j.heliyon.2024.e248223.
Otmani, K., Rouas, R., Lagneaux, L., Krayem, M., Duvillier, H., Berehab, M., & Lewalle, P. (2023). Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. Cell Communication and Signaling, 21(1), 253. doi:10.1186/s12964-023-01259-15.
Bouhtit, F., Najar, M., Rahmani, S., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Twizere, J.-C., Meuleman, N., Lewalle, P., Lagneaux, L., & Merimi, M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research, 71(7-8), 887-898. doi:10.1007/s00011-022-01573-36.
Andreozzi, F., Massaro, F., Wittnebel, S., Spilleboudt, C., Lewalle, P., & Salaroli, A. (2022). New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy. International journal of molecular sciences, 23(7), 3887. doi:10.3390/ijms230738877.
Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Moussa Agha, D., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Merimi, M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. doi:10.3389/fcell.2021.7168539.
Merimi, M., El-Majzoub, R., Lagneaux, L., Moussa Agha, D., Bouhtit, F., Meuleman, N., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Najar, M. (2021). The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.66153210.
Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers1314357911.
Merimi, M., Buyl, K., Daassi, D., Rodrigues, R. M., Melki, R., Lewalle, P., Vanhaecke, T., Fahmi, H., Rogiers, V., Lagneaux, L., De Kock, J., & Najar, M. (2021). Transcriptional profile of cytokines, regulatory mediators and tlr in mesenchymal stromal cells after inflammatory signaling and cell-passaging. International journal of molecular sciences, 22(14), 7309. doi:10.3390/ijms2214730912.
Merimi, M., Lewalle, P., Meuleman, N., Agha, D. M., El-Kehdy, H., Bouhtit, F., Ayoub, S., Burny, A., Fahmi, H., Lagneaux, L., & Najar, M. (2021). Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic. Journal of Clinical Medicine, 10(5). doi:10.3390/jcm10050905